Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms
Authors:
Open Access
- 1 March 2003
- journal article
- debate round-table
- Published by Springer Nature in Leukemia
- Vol. 17 (3) , 621-629
Abstract
Analysis of changes in recipient and donor hemopoietic cell origin is extremely useful to monitor the effect of stem cell transplantation (SCT) and sequential adoptive immunotherapy by donor lymphocyte infusions (DLI). We developed a sensitive and accurate method to quantify the percentage of recipient and donor cells by real-time PCR using single nucleotide polymorphisms (SNPs) as markers. Allele-specific PCR of seven SNPs resulted in specific markers for donor or recipient in 97% of HLA-identical sibling pairs. Both, recipient- and donor-derived hemopoietic cells can be simultaneously analyzed in 67% sibling pairs. We expect this can be increased to approximately 99% by developing three additional SNP-PCR. Serial dilution of SNP-positive DNA into either SNP-negative DNA or water revealed a detection limit of 0.1–0.01% depending on the amount of input DNA and start Ct of the used SNP-PCR. Application of our real-time SNP-PCR method for a CML patient treated by allogeneic SCT and DLI demonstrated its feasibility to follow donor T-cell chimerism and early detection of residual and recurrent autologous hemopoiesis in response to treatment. This detailed monitoring of the genetic origin of hemopoietic cells, in particular immune effector cells and target cells after SCT and DLI, may substantially contribute to understanding of the mechanisms that play a role in the success of treatment.Keywords
This publication has 54 references indexed in Scilit:
- Long-term follow-up of persisting mixed chimerism after partially T cell-depleted allogeneic stem cell transplantationLeukemia, 2002
- Chimerism testing after allogeneic stem cell transplantation: importance of timing and optimal technique for testing in different clinical–biological situationsLeukemia, 2001
- Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host diseaseBone Marrow Transplantation, 2001
- Donor lymphocyte infusionsCurrent Opinion in Hematology, 1999
- A Core Promoter and a Frequent Single-Nucleotide Polymorphism of the Mismatch Repair GenehMLH1Biochemical and Biophysical Research Communications, 1999
- Genomic identification of the minor histocompatibility antigen HA‐1 locus by allele‐specific PCRTissue Antigens, 1998
- Definition of the gene encoding the minor histocompatibility antigen HA‐1 and typing for HA‐1 from genomic DNATissue Antigens, 1998
- Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantationBone Marrow Transplantation, 1998
- Adoptive immunotherapy with donor lymphocyte transfusionsCurrent Opinion in Oncology, 1997
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995